Voraiz Drug Interactions

Metabolism/transport effects: substrate of CYP2C19 (major), CYP2C9 (major), CYP3A4 (minor).
Avoid concomitant use of Voriconazole with any of the following: Voriconazole may increase the levels/effects of: ado-trastuzumab emtansine, alfuzosin, aprepitant, astemizole, asunaprevir, avanafil, axitinib, barnidipine, bionanserin, bosutinib, bromocriptine, budesonide (systemic), ceritinib, cisapride, cobimetinib, conivaptan, crizotinib, dabrafenib, dapoxetin, domperidone, dronedarone, eletriptan, eplerenone, ergoloid mesylate, ergonovine, ergotamine, everolimus, flibanserin, halofantrine, ibrutinib, irinotecan product, isavuconazonium sulfate, ivabradine, lapatinib, lercanidipine, lomitapide, lovastatin, lurasidone, macitentan, methylergonovine, naloxegol, nilotinib, nimodipine, nisoldipine, olaparib, albociclib, pimozide, quinidine, ranolazine, red yeast rice, regorafenib, rifamycin derivatives, salmeterol, silodosin, simeprevir, simvastatin, sirolimus, sonidegib, suvorexant, tamsulosin, terfenadine, ticagrelor, tolvaptan, toremifene, ulipristal, vemurafenib, vincristine (liposomal), vorapaxar, trabectedin.
The levels/effects of Voriconazole may be increased by: atazanavir, fluconazole.
Voriconazole may decrease the levels/effects of: atazanavir, ticagrelor.
The levels/effects of Voriconazole may be decreased by: atazanavir, barbiturates, carbamazepine, lopinavir, lumacaftor, rifamycin derivatives, ritonavir, St John's Wort.